Cargando…
Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis
Aminoglycoside antibiotics are a central component of the treatment of pulmonary exacerbations of cystic fibrosis (CF) and slow the decline in lung function which ultimately causes the death of most patients. The prognosis of CF has improved, and thus side effects of treatments have become increasin...
Autores principales: | Prayle, Andrew, Watson, Alan, Fortnum, Heather, Smyth, Alan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921289/ https://www.ncbi.nlm.nih.gov/pubmed/20627927 http://dx.doi.org/10.1136/thx.2009.131532 |
Ejemplares similares
-
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis
por: McWilliam, Stephen J., et al.
Publicado: (2020) -
Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis
por: McWilliam, Stephen J., et al.
Publicado: (2020) -
Delayed publication of clinical trials in cystic fibrosis()
por: Hurley, M.N., et al.
Publicado: (2012) -
Urinary Biomarkers of Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin
por: McWilliam, Stephen J., et al.
Publicado: (2018) -
The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison
por: Prayle, A.P., et al.
Publicado: (2016)